Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hollie Noia

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2021
Culturing Primary Human Mesothelial CellsMary Mullen, Hollie Noia, Katherine Fuh
Gynecologic Oncology|November 21, 2025
AXL inhibition improves the therapeutic efficacy of trastuzumab in high-risk endometrial cancerJo'an Tankou, Sofia Ruau, Anjali Walia, et al.
Scientific Reports|March 20, 2019
p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenograftsKathryn A Mills, Jeanne M Quinn, S Tanner Roach, et al.
Nucleic Acids Research|June 29, 2024
A RAD18-UBC13-PALB2-RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cellsEmily Cybulla, Sierra Wallace, Alice Meroni, et al.
Cancers|December 10, 2021
Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous CancerMichael D Toboni, Elena Lomonosova, Shaina F Bruce, et al.
Molecular Cancer Therapeutics|May 19, 2022
GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell GlycolysisShaina F Bruce, Kevin Cho, Hollie Noia, et al.
Molecular Cancer Research : MCR|March 3, 2026
Correction: GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication StressMary M Mullen, Elena Lomonosova, Michael D Toboni, et al.
Molecular Cancer Research : MCR|October 21, 2021
GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication StressMary M Mullen, Elena Lomonosova, Michael D Toboni, et al.
Molecular Cancer Research : MCR|August 1, 2023
Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix ProteinsAngela M Schab, Molly M Greenwade, Elizabeth Stock, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2021
Culturing Primary Human Mesothelial CellsMary Mullen, Hollie Noia, Katherine Fuh
Gynecologic Oncology|November 21, 2025
AXL inhibition improves the therapeutic efficacy of trastuzumab in high-risk endometrial cancerJo'an Tankou, Sofia Ruau, Anjali Walia, et al.
Scientific Reports|March 20, 2019
p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenograftsKathryn A Mills, Jeanne M Quinn, S Tanner Roach, et al.
Nucleic Acids Research|June 29, 2024
A RAD18-UBC13-PALB2-RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cellsEmily Cybulla, Sierra Wallace, Alice Meroni, et al.
Cancers|December 10, 2021
Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous CancerMichael D Toboni, Elena Lomonosova, Shaina F Bruce, et al.
Molecular Cancer Therapeutics|May 19, 2022
GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell GlycolysisShaina F Bruce, Kevin Cho, Hollie Noia, et al.
Molecular Cancer Research : MCR|March 3, 2026
Correction: GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication StressMary M Mullen, Elena Lomonosova, Michael D Toboni, et al.
Molecular Cancer Research : MCR|October 21, 2021
GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication StressMary M Mullen, Elena Lomonosova, Michael D Toboni, et al.
Molecular Cancer Research : MCR|August 1, 2023
Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix ProteinsAngela M Schab, Molly M Greenwade, Elizabeth Stock, et al.
Pageof 1